BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.
BioNxt Solutions Stock Performance
Shares of OTCMKTS:BNXTF traded down $0.02 during trading on Friday, reaching $0.29. 5,000 shares of the stock traded hands, compared to its average volume of 3,186. The stock has a 50-day moving average of $0.35 and a two-hundred day moving average of $0.42. BioNxt Solutions has a 52-week low of $0.14 and a 52-week high of $0.80. The stock has a market cap of $35.04 million, a P/E ratio of -7.15 and a beta of 0.69.
BioNxt Solutions Company Profile
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Featured Stories
- Five stocks we like better than BioNxt Solutions
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
